Corcept Therapeutics Inc
CORT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$8.88M | -$5.70M |
| EPS Diluted | -$0.11 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR